SCHEMBL481037

SCHEMBL481037

CC(=O)Nc1nc(-c2cc(Cl)c(OCC(C)(C)C)c(Cl)c2)cs1

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 8/20 0.60
TRPA1 O75762 5/20 0.59
ALDH1A1 P00352 2/20 0.49
HSD17B10 Q99714 2/20 0.49
MEN1 O00255 1/20 0.49
ALOX15 P16050 1/20 0.49
MAPK1 P28482 1/20 0.49
KMT2A Q03164 1/20 0.49
RAB9A P51151 4/20 0.48
NPC1 O15118 3/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TYR P14679 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480792 0.88 TRPA1 (0.61) ABL1TRPA1RAB9ANPC1
SCHEMBL480700 0.81 TRPA1 (0.55) ABL1TRPA1MEN1KMT2ARAB9A
SCHEMBL18724281 0.78 ABL1 (0.67) ABL1ALDH1A1HSD17B10MEN1ALOX15
SCHEMBL474447 0.78 TRPA1 (0.45) TRPA1ALDH1A1MEN1KMT2ARAB9A
SCHEMBL2445031 0.77 TRPA1 (0.76) TRPA1SMN1; SMN2
SCHEMBL6984546 0.76 ABL1 (0.69) ABL1ALDH1A1HSD17B10MEN1ALOX15
SCHEMBL608664 0.75 ABL1 (0.52) ABL1TRPA1ALDH1A1HSD17B10MEN1
SCHEMBL609868 0.75 TRPA1 (1.00) TRPA1SMN1; SMN2
SCHEMBL25735740 0.75 ABL1 (1.00) ABL1ALDH1A1HSD17B10MEN1ALOX15
SCHEMBL2443035 0.75 MAPT (0.49) ABL1TRPA1MAPK1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411393-A1 FUSED PYRIMIDINE-DIONE DERIVATIVES AS TRPA1 MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2012-02-01 EP disclosed
WO-2010109287-A1 FUSED PYRIMIDINE-DIONE DERIVATIVES AS TRPA1 MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2010-09-30 WO disclosed